Tag: MM

Annals of Oncology

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment...

Multiple myeloma (MM) is a plasma cell neoplasm that accounts for 1%-1.8% of all cancers and is the second most common haematological malignancy with an estimated incidence in Europe of 4.5-6.0/100 000/year.

Visit website
Lancet Guidelines

Treatment of relapsed and refractory multiple myeloma: recommendations from the ...

This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma.

Visit website
Immunotherapy Web Featured Images 115

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for...

Outcomes in multiple myeloma (MM) have improved dramatically in the last two decades with the advent of novel therapies including immunomodulatory agents (IMiDs), proteasome inhibitors and monoclonal antibodies.

Visit website